Camilla Comin - Concepedia

Author

Camilla Comin

University of Florence

Also Known As

C COMIN, C Comin, C E Comin, C E. Comin, C. Comin, C. E. Comin, C.E. Comin, CE Comin, CLARA MANNESCHI, Camilla Comin

108

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University of Florence Azienda Ospedaliero-Universitaria Careggi Piedmont Reference Center for Epidemiology and Cancer Prevention University of Rome Tor Vergata Karolinska Institutet

About

Camilla Comin is an author at University of Florence specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	1.9K
2	Engineering	4	4	539
3	Health Sciences	2	2	427
4	Allergy	2	2	48
5	Allergy Medicine	1	1	15

Camilla Comin

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT Andrea Lopes Pegna, Giulia Picozzi, Mario Mascalchi, Lung Cancer Italung TrialOncologyMedical ImagingAdvanced Lung DiseaseCancer Screening	2008	288
RETRACTED: The first tissue-engineered airway transplantation: 5-year follow-up results Alessandro Gonfiotti, Massimo Osvaldo Jaus, Daniel Barale, The Lancet Regenerative MedicineTransplantation SurgeryTissue EngineeringEngineeringMedicine	2013	270
Adenocarcinoma classification: patterns and prognosis. Elisabetta Kuhn, Patrizia Morbini, Alessandra Cancellieri, PubMed Tumor BiologyWorld Health OrganizationSurgical OncologyTumoral PathologyMedicine	2018	140
Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial Andrea Lopes Pegna, Giulia Picozzi, Fabio Falaschi, Journal of Thoracic Oncology Computed TomographyItalung TrialMedical ImagingMedicineMultiple Pulmonary Nodule	2013	139
h-Caldesmon, Calretinin, Estrogen Receptor, and Ber-EP4: A Useful Combination of Immunohistochemical Markers for Differentiating Epithelioid Peritoneal Mesothelioma From Serous Papillary Carcinoma of the Ovary Camilla Comin, Calogero Saieva, Luca Messerini The American Journal of Surgical Pathology Tumoral PathologyUseful CombinationImmunohistochemical MarkersMedicineSurgical Pathology	2007	133
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas Hannelore Kothmaier, Stephanie R. Land, Yongli Shuai, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin MedicinePathologyPleural DiseaseP16/cdkn2a LossOncology	2008	116
Calretinin, thrombomodulin, CEA, and CD15: A useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma Camilla Comin, Luca Novelli, Vieri Boddi, Human Pathology Useful CombinationMedicinePathologyPleural EffusionBronchial Neoplasm	2001	113
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy Roberta Minari, Paola Bordi, Marzia Del Re, Lung Cancer MedicineSclc TransformationT790m DeterminationPharmacologyPathology	2017	106
Development of bioengineered human larynx Silvia Baiguera, Alessandro Gonfiotti, Massimo Osvaldo Jaus, Biomaterials Tissue EngineeringBiomanufacturingEngineeringBioengineering ModelLaryngectomy	2011	100
Long-term changes to in vitro preserved bioengineered human trachea and their implications for decellularized tissues Silvia Baiguera, Costantino Del Gaudio, Massimo Osvaldo Jaus, Biomaterials Regenerative MedicineTissue EngineeringBioengineered Human TracheaDecellularized TissuesEngineering	2012	92

Page 1